United Services Automobile Association Takes Position in Agilent Technologies, Inc. $A

United Services Automobile Association acquired a new position in Agilent Technologies, Inc. (NYSE:A) in the first quarter, HoldingsChannel reports. The fund acquired 6,845 shares of the medical research company’s stock, valued at approximately $799,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in A. Whipplewood Advisors LLC increased its position in Agilent Technologies by 286.2% during the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company’s stock valued at $29,000 after purchasing an additional 186 shares during the period. Sunbelt Securities Inc. boosted its stake in shares of Agilent Technologies by 640.0% during the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 192 shares in the last quarter. Stone House Investment Management LLC purchased a new position in Agilent Technologies during the first quarter valued at approximately $30,000. Opal Wealth Advisors LLC purchased a new position in Agilent Technologies during the first quarter valued at approximately $31,000. Finally, Wood Tarver Financial Group LLC bought a new position in Agilent Technologies in the fourth quarter worth approximately $34,000.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the firm’s stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares in the company, valued at $4,397,893.12. This trade represents a 3.87% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Analyst Ratings Changes

Several brokerages have issued reports on A. UBS Group dropped their target price on Agilent Technologies from $150.00 to $130.00 and set a “neutral” rating on the stock in a research report on Thursday, May 29th. Barclays reaffirmed an “equal weight” rating and set a $125.00 price objective on shares of Agilent Technologies in a research report on Friday, August 29th. Robert W. Baird lifted their target price on Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research note on Thursday, August 28th. Leerink Partners boosted their target price on shares of Agilent Technologies to $135.00 and gave the stock a “buy” rating in a report on Friday, May 30th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Agilent Technologies from $160.00 to $155.00 and set an “overweight” rating on the stock in a report on Thursday, May 29th. Six investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $139.25.

Agilent Technologies Stock Down 0.5%

A stock opened at $128.13 on Tuesday. The stock has a market capitalization of $36.32 billion, a PE ratio of 30.08, a price-to-earnings-growth ratio of 4.00 and a beta of 1.24. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The firm has a 50 day moving average of $119.42 and a 200 day moving average of $116.00.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter in the prior year, the business posted $1.32 EPS. Agilent Technologies’s revenue for the quarter was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.